Literature DB >> 30546668

Cryptogenic stroke prevention through venous thromboembolism prevention: Potential and truth in the advent of non-vitamin K antagonist oral anticoagulants.

Kengo Ayabe1, Shinya Goto1.   

Abstract

Entities:  

Year:  2016        PMID： 30546668      PMCID： PMC6282923          DOI： 10.1016/j.jccase.2016.06.009

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN： 1878-5409


× No keyword cloud information.
  15 in total

1.  Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Authors:  Harry R Büller; Hervé Décousus; Michael A Grosso; Michele Mercuri; Saskia Middeldorp; Martin H Prins; Gary E Raskob; Sebastian M Schellong; Lee Schwocho; Annelise Segers; Minggao Shi; Peter Verhamme; Phil Wells
Journal:  N Engl J Med       Date:  2013-08-31       Impact factor: 91.245

2.  How can we bridge the results of global clinical trials and region/country specific clinical practice by region/country specific registry data?

Authors:  Shinichi Goto; Shinya Goto
Journal:  Circ J       Date:  2014-12-24       Impact factor: 2.993

3.  Oral apixaban for the treatment of acute venous thromboembolism.

Authors:  Giancarlo Agnelli; Harry R Buller; Alexander Cohen; Madelyn Curto; Alexander S Gallus; Margot Johnson; Urszula Masiukiewicz; Raphael Pak; John Thompson; Gary E Raskob; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2013-07-01       Impact factor: 91.245

4.  Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan.

Authors:  S Fujita; S Hirota; T Oda; Y Kato; Y Tsukamoto; T Fuji
Journal:  Clin Orthop Relat Res       Date:  2000-06       Impact factor: 4.176

5.  Oral rivaroxaban for symptomatic venous thromboembolism.

Authors:  Rupert Bauersachs; Scott D Berkowitz; Benjamin Brenner; Harry R Buller; Hervé Decousus; Alex S Gallus; Anthonie W Lensing; Frank Misselwitz; Martin H Prins; Gary E Raskob; Annelise Segers; Peter Verhamme; Phil Wells; Giancarlo Agnelli; Henri Bounameaux; Alexander Cohen; Bruce L Davidson; Franco Piovella; Sebastian Schellong
Journal:  N Engl J Med       Date:  2010-12-03       Impact factor: 91.245

6.  Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

Authors:  Sam Schulman; Clive Kearon; Ajay K Kakkar; Patrick Mismetti; Sebastian Schellong; Henry Eriksson; David Baanstra; Janet Schnee; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

7.  Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study.

Authors:  Steven C Cramer; Guy Rordorf; Jeffrey H Maki; Larry A Kramer; James C Grotta; W Scott Burgin; Judith A Hinchey; Curtis Benesch; Karen L Furie; Helmi L Lutsep; Ellen Kelly; W T Longstreth
Journal:  Stroke       Date:  2003-12-04       Impact factor: 7.914

Review 8.  Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.

Authors:  Nick van Es; Michiel Coppens; Sam Schulman; Saskia Middeldorp; Harry R Büller
Journal:  Blood       Date:  2014-06-24       Impact factor: 22.113

9.  Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.

Authors:  Sam Schulman; Ajay K Kakkar; Samuel Z Goldhaber; Sebastian Schellong; Henry Eriksson; Patrick Mismetti; Anita Vedel Christiansen; Jeffrey Friedman; Florence Le Maulf; Nuala Peter; Clive Kearon
Journal:  Circulation       Date:  2013-12-16       Impact factor: 29.690

Review 10.  Patent Foramen Ovale and Stroke-Current Status.

Authors:  Oh Young Bang; Mi Ji Lee; Sookyung Ryoo; Suk Jae Kim; Ji Won Kim
Journal:  J Stroke       Date:  2015-09-30       Impact factor: 6.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.